[HTML][HTML] Vaccine effectiveness of primary and booster COVID-19 vaccinations against SARS-CoV-2 infection in the Netherlands from July 12, 2021 to June 6, 2022: A …

AJ Huiberts, B de Gier, CE Hoeve, HE de Melker… - International Journal of …, 2023 - Elsevier
Objectives We estimated vaccine effectiveness (VE) of primary and booster vaccinations
against SARS-CoV-2 infection overall and in four risk groups defined by age and medical …

Neighbourhood sociodemographic factors and COVID-19 vaccine uptake in the Netherlands: an ecological analysis

LJE Labuschagne, N Smorenburg… - BMC Public Health, 2023 - Springer
Background While overall COVID-19 vaccine uptake is high in the Netherlands, it lags
behind in certain subpopulations. Aim We aimed to explore the characteristics of groups with …

COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to …

CE van Ewijk, MN Kooijman, E Fanoy… - …, 2022 - eurosurveillance.org
Background Differential SARS-CoV-2 exposure between vaccinated and unvaccinated
individuals may confound vaccine effectiveness (VE) estimates. Aim We conducted a test …

Increase in invasive disease caused by Haemophilus influenzae b, the Netherlands, 2020 to 2021

A Steens, KR Stanoeva, MJ Knol, R Mariman… - …, 2021 - eurosurveillance.org
The incidence of most respiratory-transmitted diseases decreased during the COVID-19
pandemic as a result of containment measures. In contrast, in the Netherlands we noted an …

[HTML][HTML] Design and baseline description of an observational population-based cohort study on COVID-19 vaccine effectiveness in the Netherlands-The VAccine …

AJ Huiberts, MN Kooijman, HE de Melker, SJ Hahne… - 2022 - europepmc.org
Abstract VAccine Study COvid-19 (VASCO) is a cohort study with 5-year follow-up to assess
the real-world vaccine effectiveness (VE) of COVID-19 vaccines in the Netherlands. VASCO …

Vaccine effectiveness against severe acute respiratory syndrome coronavirus 2 delta and omicron infection and infectiousness within households in the Netherlands …

CE Hoeve, B de Gier, AJ Huiberts… - The Journal of …, 2023 - academic.oup.com
Background We aimed to estimate vaccine effectiveness against infection (VE-infection) and
against further transmission (VE-infectiousness) in a household setting during Delta and …

Information bias of vaccine effectiveness estimation due to informed consent for national registration of COVID-19 vaccination: estimation and correction using a data …

CH Van Werkhoven, B de Gier, S McDonald… - medRxiv, 2023 - medrxiv.org
ABSTRACT Background Registration in the Dutch national COVID-19 vaccination register
requires consent from the vaccinee. This causes misclassification of non-consenting …

Selective under-representation of Pacific peoples in population estimates for health indicator measurements in Aotearoa New Zealand misinforms policy making

GJB Sonder, C Grey, D Ryan, J Cumming, A Sporle… - BMC public health, 2024 - Springer
Abstract Background The Census of Populations and Dwellings' is the five yearly population
count of Aotearoa New Zealand. Best available populations (BAP) are subnational …

Vaccine effectiveness against SARS-CoV-2 Delta and Omicron infection and infectiousness within households in the Netherlands between July 2021 and August …

CE Hoeve, B de Gier, AJ Huiberts, HE de Melker… - medRxiv, 2023 - medrxiv.org
Introduction We aimed to estimate vaccine effectiveness against infection (VE-infection) and
infectiousness (VE-infectiousness) in a household setting during Delta and Omicron …

[PDF][PDF] Pandemi Tarihi, COVID-19 Pandemisi, Küresel ve Ulusal Mücadele Süreçleri

F YILMAZ - researchgate.net
©️ 2024. Telif hakkı yazarlara aittir. Bu kitaptaki bölümler açık erişimli olup Creative
Commons Atıf 4.0 Uluslararası Lisansı altında dağıtılmaktadır. Bu lisans kullanıcılara …